2023•EFSA JournalOpen access

Safety and efficacy of a feed additive consisting of β‐mannanase produced by Aspergillus niger CBS 120604 (Nutrixtend Optim) for use in all poultry for fattening (Kerry Ingredients & Flavours Ltd)

EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP Panel), Vasileios Bampidis, Giovanna Azimonti, Maria de Lourdes Bastos, Henrik Kidmose Christensen, Birgit Dusemund, Mojca Fašmon Durjava, Maryline Kouba, Marta López‐Alonso, Secundino López Puente, Francesca Marcon, Baltasar Mayo, Alena Pechová, Mariana Petkova, Fernando Ramos, Yolanda Sanz, Roberto Edoardo Villa, Ruud Woutersen, Giovanna Martelli, Luca Tosti, Montserrat Anguita, Yolanda García‐Cazorla, Elisa Pettenati, Jordi Ortuño

Open full text 2 citations

Abstract

Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of a product containing b-mannanase produced by a non-genetically modified strain of Aspergillus niger (CBS 120604).The commercial name is Nutrixtend Optim and it is intended to be used as a zootechnical feed additive for all poultry for fattening.Based on a tolerance trial in chickens for fattening and the no observed adverse effect level identified in a subchronic oral toxicity study in rats, the additive was considered safe for all poultry for fattening.The Panel concluded that the use of the product as a feed additive does not give rise to concerns for consumers and the environment.The additive is considered an irritant to skin and eyes and a dermal sensitiser.Due to the proteinaceous nature of the active substance, it is also considered a respiratory sensitiser.The Panel concludes that the additive has the potential to be efficacious as a zootechnical additive at the level of inclusion in feed of chickens for fattening of 30 U b-mannanase/kg complete feed.This conclusion was extrapolated to all poultry for fattening.

Open-access reader

About this research paper

What this paper is about

Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of a product containing b-mannanase produced by a non-genetically modified strain of Aspergillus niger (CBS 120604).The commercial name is Nutrixtend Optim and it is intended to be used as a zootechnical feed additive for all poultry for fattening.Based on a tolerance trial in chickens for fattening and the no observed adverse effect level identified in a subchronic oral toxicity study in rats, the additive was considered safe for all poultry for fattening.The Panel concluded that the use of the product as a feed additive does not give rise to concerns for consumers and the environment.The additive is considered an irritant to skin and eyes and a dermal sensitiser.Due to the proteinaceous nature of the active substance, it is also considered a respiratory sensitiser.The Panel concludes that the additive has the potential to be efficacious as a zootechnical additive at the level of inclusion in feed of chickens for fattening of 30 U b-mannanase/kg complete feed.This conclusion was extrapolated to all poultry for fattening.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Following a request from the European Commission, the EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of a product containing b-mannanase produced by a non-genetically modified strain of Aspergillus niger (CBS 120604).The commercial name is Nutrixtend Optim and it is intended to be used as a zootechnical feed additive for all poultry for fattening.Based on a tolerance trial in chickens for fattening and the no observed adverse effect level identified in a subchronic oral toxicity study in rats, the additive was considered safe for all poultry for fattening.The Panel concluded that the use of the product as a feed additive does not give rise to concerns for consumers and the environment.The additive is considered an irritant to skin and eyes and a dermal sensitiser.Due to the proteinaceous nature of the active substance, it is also considered a respiratory sensitiser.The Panel concludes that the additive has the potential to be efficacious as a zootechnical additive at the level of inclusion in feed of chickens for fattening of 30 U b-mannanase/kg complete feed.This conclusion was extrapolated to all poultry for fattening.

Key concepts: Feed additive, Animal feed, Aspergillus niger, Food science, European commission, Biotechnology, Feed conversion ratio, Food additive

Related papers

Back to paper searchBrowse research topicsOriginal source
Safety and efficacy of a feed additive consisting of β‐mannanase produced by Aspergillus niger CBS 120604 (Nutrixtend Optim) for use in all poultry for fattening (Kerry Ingredients & Flavours Ltd) — Research Paper | ScholarLens